Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma-associated antigen B4 (MAGEB4) is a member of the MAGE-B subfamily within the larger MAGE (Melanoma Antigen Gene) family, whose members were initially identified as tumor antigens with restricted expression patterns. MAGEB4 is encoded by the MAGEB4 gene on the X chromosome, with expression highly specific to germ cells, particularly in the testis and, during developmental periods, in the ovary. In the testis, MAGEB4 protein localizes to the cytoplasm of spermatogonia and is downregulated as cells enter meiosis; in the ovary, it is expressed in oocytes during meiosis and dormancy[1][2][3]. Human and mouse MAGEB4 genes are homologous, and the gene has been implicated in inherited male infertility and disorders of sex development, though knockout mouse models suggest MAGEB4 is dispensable for normal fertility[1]. Functionally, MAGEB4 may play a role in regulating spermatogonial apoptosis and differentiation, possibly via protein-protein interactions such as those involving E3 ubiquitin ligases[3]. MAGEB4 is categorized as a cancer/testis antigen but is not a receptor, enzyme, transporter, or common drug target, and no approved or experimental drugs are known to interact with it. Its role in normal physiology appears limited to specialized reproductive functions, and it is occasionally used as a biomarker in cancer and germ cell research[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma-associated antigen B4 (MAGEB4).